☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Vertex Receives EU's MAA for Symkevi (tezacaftor/ivacaftor) + Kalydeco (Ivacaftor) to Treat Patients with CF aged ≥12yrs. with Mut...
November 2, 2018
Aileron Therapeutics & Dana-Farber/Boston Children's Cancer and Blood Disorders Center Enters into a Clinical Collaboration to...
November 2, 2018
AbbVie Exercises its Option to License Agreement for BioArctic's Alpha-Synuclein Antibody Portfolio- Signed in 2016
November 2, 2018
Illumina Acquires Pacific Biosciences for ~$1.2B with its Sequel SMRT Technology
November 2, 2018
Coherus' Udenyca (pegfilgrastim-cbqv) Receives the US FDA Approval for Patients Receiving Myelosuppressive Chemotherapy
November 2, 2018
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions